Publication: Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study.
No Thumbnail Available
Identifiers
Date
2021-03-19
Authors
De la Rosa Carrillo, David
Martínez-García, Miguel Ángel
Barreiro, Esther
Tabernero Huguet, Eva
Costa Sola, Roser
García-Clemente, Marta María
Celorrio Jiménez, Nuria
Rodríguez Pons, Laura
Calero Acuña, Carmen
Rodríguez Hermosa, Juan Luís
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
We aimed to describe the effectiveness and safety of inhaled antibiotics in chronic obstructive pulmonary disease (COPD) patients, as well as the patient profile in which they are usually prescribed and the patient groups that can most benefit from this treatment. Multicentre retrospective observational cohort study in COPD patients who had received ≥1 dose of inhaled antibiotics in the last 5 years. Clinical data from the two years prior to and subsequent to the start of the treatment were compared. COPD exacerbations. side effects, symptomatology (sputum purulence, dyspnoea), microbiological profile and pathogen eradication. Of 693 COPD patients analyzed (aged 74.1; 86.3% men; mean FEV1=43.7%), 71.7% had bronchiectasis and 46.6% presented chronic bronchial infection (CBI) by Pseudomonas aeruginosa (PA). After 1 year of treatment with inhaled antibiotics, there was a significant decrease in the number of exacerbations (-33.3%; P In COPD patients with multiple exacerbations and/or CBI by any PPM (especially PA), inhaled antibiotics appear to be an effective and safe treatment, regardless of the presence of bronchiectasis.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Antibióticos inhalados, Bronchiectasis, Bronquiectasia, Chronic bronchial infection, Chronic obstructive pulmonary disease, Enfermedad pulmonar obstructiva crónica, Exacerbaciones, Exacerbations, Infección bronquial crónica, Inhaled antibiotics, Pseudomonas aeruginosa